EMERYVILLE, Calif.,
Nov. 23, 2021 /PRNewswire/
-- Amyris, Inc. (Nasdaq: AMRS) ("Amyris"), a leading synthetic
biotechnology company accelerating the world to sustainable
consumption through its Lab-to-Market™ operating
platform, today announced that management will participate in a
fireside chat at the Evercore ISI 4th Annual HealthCONx
Conference on Wednesday, December
1st at 3:30 pm
ET.
A live webcast of the presentation and a replay will be
available on the Investor Relations section of the company's
website at
https://investors.amyris.com/events-and-presentations.
About Amyris
Amyris (Nasdaq: AMRS) is a leading
synthetic biotechnology company, transitioning the Clean Health
& Beauty and Flavors & Fragrances markets to sustainable
ingredients through fermentation and the company's proprietary
Lab-to-Market™ operating platform. This Amyris
platform leverages state-of-the-art machine learning, robotics and
artificial intelligence, enabling the company to rapidly bring new
innovation to market at commercial scale. Amyris ingredients are
included in over 20,000 products from the world's top brands,
reaching more than 300 million consumers. Amyris also owns and
operates a family of consumer brands that is constantly evolving to
meet the growing demand for sustainable, effective and accessible
products.
Amyris, the Amyris logo and Lab-to-Market are trademarks or
registered trademarks of Amyris, Inc. in the U.S. and/or other
countries.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/amyris-to-present-at-the-evercore-isi-4th-annual-healthconx-conference-on-december-1-2021-301431144.html
SOURCE Amyris, Inc.